Finance

Lists
185490:KOSDAQ
EyeGene Inc
â‚©2,105.00
+0.72%
(+15.00) 1D
Sep 9, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 185490...
Open
â‚©2,095
High
â‚©2,135
Low
â‚©2,035
Mkt. cap
91.00B
Avg. vol.
214.11K
Volume
108.59K
52-wk high
â‚©2,805
52-wk low
â‚©1,182
EPS
-â‚©729
Shares outstanding
43.23M
No. of employees
47
Open
â‚©2,095
High
â‚©2,135
Low
â‚©2,035
Mkt. cap
91.00B
Avg. vol.
214.11K
Volume
108.59K
52-wk high
â‚©2,805
52-wk low
â‚©1,182
EPS
-â‚©729
Shares outstanding
43.23M
No. of employees
47
About EyeGene Inc
CEOYoo Won-jin
Employees47
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.10B
774.00M
1.27B
1.34B
Cost of goods sold
783.84M
537.77M
930.51M
1.03B
Cost of revenue
783.84M
537.77M
930.51M
1.03B
Research and development expenses
630.81M
2.37B
2.55B
2.95B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.18B
993.56M
1.18B
1.18B
Operating expense
1.96B
3.57B
3.87B
4.26B
Total operating expenses
2.75B
4.11B
4.80B
5.29B
Operating income
-1.65B
-3.34B
-3.53B
-3.95B
Other non operating income
306.00M
654.22M
-279.68M
232.65M
EBT including unusual items
-1.57B
-12.06B
-3.56B
-3.84B
EBT excluding unusual items
-1.57B
-2.65B
-3.58B
-3.84B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
39.30M
15.05M
32.93M
29.59M
Net income
-1.52B
-8.83B
-3.45B
-3.75B
Net profit margin
-138.08%
-1,141.38%
-271.35%
-280.03%
Earnings per share
-
-
-
-
Interest and investment income
-
146.65M
577.01M
-
Interest expense
-174.26M
-105.75M
-111.24M
-116.58M
Net interest expenses
-174.26M
40.90M
465.76M
-116.58M
Depreciation and amortization charges
110.75M
107.08M
102.25M
101.56M
EBITDA
-1.14B
-2.84B
-3.01B
-3.46B
Gain or loss from assets sale
12.38M
152.26M
-
11.95M
AI content may include mistakes. Learn more
Google apps